The Actavis Group Company Profile

00:58 EDT 21st March 2018 | BioPortfolio

Actavis' recent acquisition of the generics business of Alpharma positions the company among the five leading generic pharmaceutical companies in the world, with 10,000 employees in over 30 countries. Founded in 1956, the Group now operates across five continents and has its headquarters in Iceland. Today the Company has modern development and manufacturing facilities in Europe, the US and Asia. The plants produce a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi solids


Dalshrauni 1, 220


Phone: 354 535-2300
Fax: 354 535-2301

News Articles [333 Associated News Articles listed on BioPortfolio]

English Court gives green light to Actavis for generic version of Alimta® in UK, France, Spain and Italy on basis of reconstitution in dextrose

Précis In a recent decision (Actavis & ors v Eli Lilly [2016] EWHC 234 (Pat)), the English High Court has granted declarations of non-infringement to Actavis, which was “clearing the ...

Celgene Settlement With Actavis Allows Abraxane Generics In 2022

Celgene settles Abraxane patent litigation and inter partes review with Teva's Actavis, allowing a generic to enter the market on...  

Neos Therapeutics Announces Settlement with Actavis on Adzenys XR-ODT® Patent Litigation

DALLAS and FORT WORTH, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovativ...

Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER

MORRISTOWN, N.J., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that it has entered into a settlement agre...

Industry cleaning up its act after Actavis case, FTC report shows

For the second year running, pay-for-delay deals declined in 2015, the Federal Trade Commission (FTC)…

Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Revision: 9, Authorised

Human medicines European public assessment report (EPAR): Imatinib Actavis, imatinib, Revision: 9, Authorised

Actavis makes Teva a US co in SEC's book

After being classified as a US domestic issuer, Teva has had to report senior managers and directors' shareholdings.

PubMed Articles [1829 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement.

The success of fluorinated molecules in drug design has led medicinal chemists to search for new fluorine-containing substituents. A major recently developed group is the pentafluorosulfanyl group. Th...

Systemic granulomatous disease in dairy cattle during a dicyandiamide feeding trial.

Mature, in-calf, non-lactating, Friesian or Friesian-cross cows were fed dicyandiamide (DCD) at daily doses of 0.15 g/kg (Group 1; n=31), 0.45 g/kg (Group 2; n=21) and 0.75 g/kg (Group 3; n=12), as pa...

Clinical Trials [3542 Associated Clinical Trials listed on BioPortfolio]

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions

The purpose of this study is to compare the rate and extent of absorption of Actavis Group hf, Iceland, finasteride and Merck & Co. Inc., U.S.A. (Proscar), finasteride, administered as a 1...

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions

The purpose of this study to assess the single-dose relative bioavailability of Actavis Group hf and Pfizer (Norvasc®) 10 mg amlodipine besylate tablets, under fasting conditions.

A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions

The purpose of this study to assess the single-dose relative bioavailability of Actavis Group hf 50 mg venlafaxine hydrochloride tablets with Wyeth Pharmaceuticals (Effexor®) 50 mg venlaf...

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC h...

Clinical Endpoint Study of Ivermectin 0.5% Lotion

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Ivermectin Lotion 0.5% (Actavis Laborato...

Companies [1602 Associated Companies listed on BioPortfolio]

Actavis Inc.

Actavis Inc. is the U.S. subsidiary of Actavis Group hf. Approximately one third of Actavis' sales are generated in North America, Actavis' single largest market. Based in Morristown, NJ, Actavis has ...

Actavis Group

Actavis is a fast growing company, headquartered in Iceland with modern development and manufacturing facilities in Europe, the U.S. and Asia and an extensive sales and marketing network in five conti...

The Actavis Group

Actavis' recent acquisition of the generics business of Alpharma positions the company among the five leading generic pharmaceutical companies in the world, with 10,000 employees in over 30 countries....

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

TransCelerate BioPharma Inc.

TransCelerate BioPharma Inc. is a non-profit organization dedicated to improving the health of people around the world by accelerating and enhancing the research and development (...

More Information about "The Actavis Group" on BioPortfolio

We have published hundreds of The Actavis Group news stories on BioPortfolio along with dozens of The Actavis Group Clinical Trials and PubMed Articles about The Actavis Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Actavis Group Companies in our database. You can also find out about relevant The Actavis Group Drugs and Medications on this site too.

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Corporate Database Quicklinks

Searches Linking to this Company Record